HPSE and breast cancer: In breast cancer, miR-1258 alterations were directly related to heparanase expression, a known prometastatic enzyme found in brain metastatic breast cancer cells that degrades heparan sulfate chains to affect the cytoskeleton and render cells more capable of crossing the BBB [41,42].